Though renal cell carcinoma (RCC) accounts for 2% of global cancer diagnoses and deaths,
it has more than doubled in incidence in the developed world over the past half-century, and …

Computational pathology is currently witnessing a surge in the development of AI
techniques, offering promise for achieving breakthroughs and significantly impacting the …

Recently, long noncoding RNAs (lncRNA) have emerged as new gene regulators and
prognostic markers in several cancers, including renal cell carcinoma (RCC). In this study …

Objectives To examine racial differences in the distribution of histological subtypes of renal
cell carcinoma (RCC) and associations with established RCC risk factors by subtype …

Serum biomarkers have not been fully incorporated into clinical use for the diagnosis of
renal cell carcinoma (RCC). The recent discovery of long noncoding RNAs (lncRNAs), which …

Introduction In recent years, molecular characterization of renal cell carcinoma has
facilitated the identification of driver genes, specific molecular pathways, and …

Renal cell carcinoma (RCC) records for 2% of all cancer assessments and mortality
worldwide, and its severity has more than doubled in the world over the last half-century …

Objective Black women with uterine cancer on average have worse survival outcomes
compared to White women, in part due to higher rates of aggressive, non-endometrioid …

Here, in a multi-ancestry genome-wide association study meta-analysis of kidney cancer
(29,020 cases and 835,670 controls), we identified 63 susceptibility regions (50 novel) …

Objectives Long non‐coding RNA s (lnc RNA s) are characterized as a group of RNA s that
more than 200 nucleotides in length and have no protein‐coding function. More and more …